Aldeyra Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | -86.4% | -81.7% | -74.2% |
| FY2017 | -56.4% | -54.7% | -50.6% |
| FY2018 | -44.9% | -44.9% | -40.9% |
| FY2019 | -126.5% | -97.2% | -80.5% |
| FY2020 | -63.1% | -52.9% | -45.1% |
| FY2021 | -28.1% | -26.1% | -24.8% |
| FY2022 | -41.1% | -37.4% | -34.2% |
| FY2023 | -31.3% | -31.3% | -25.3% |
| FY2024 | -78.7% | -64.9% | -53.4% |
| FY2025 | -76.5% | -76.5% | -47.0% |